SVA
NASDAQ · Biotechnology
Sinovac Biotech Ltd
$6.47
+0.00 (+0.00%)
Open$6.47
Previous Close$6.47
Day High$6.47
Day Low$6.47
52W High$6.47
52W Low$6.47
Volume—
Avg Volume0
Market Cap639.90M
P/E Ratio—
EPS$-1.25
SectorBiotechnology
Key Financials
| FY 2026 | FY 2025 | |
|---|---|---|
| Revenue | 445.10M | 464.96M |
| Net Income | -99,209,845 | -93,271,555 |
| Profit Margin | -22.3% | -21.2% |
| EBITDA | -94,749,309 | -94,026,787 |
| Free Cash Flow | — | — |
| Rev Growth | -4.3% | -4.3% |
| Debt/Equity | 0.03 | 0.03 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $255.48 | -1.03% | 70.2 | 443.23B |
| AMGN | Amgen Inc | $432.42 | -1.05% | 25.8 | 225.90B |
| GILD | Gilead Sciences Inc | $145.68 | -2.14% | — | 169.87B |
| VRTX | Vertex Pharmaceuticals Inc | $541.69 | -1.07% | 30.7 | 135.24B |
| REGN | Regeneron Pharmaceuticals | $794.19 | -1.67% | 19.0 | 82.16B |
| ALNY | Alnylam Pharmaceuticals Inc | $237.10 | +0.23% | 37.6 | 30.39B |